Jubilant Pharmova Limited (JUBLPHARMA.NS) NSE
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Jubilant Pharmova Limited
Address
1A, Sector 16A
Noida, UP 201301
India
Phone
91 12 0436 1000
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
5399
First IPO Date
July 01, 2002
Key Executives
| Name | Title | Pay | Year Born |
| Naresh Kapoor | Company Secretary & Compliance Officer | 6.86M | 1974 |
| Rajagopal Sankaraiah | Advisor | 67.29M | 1959 |
| Priyavrat Bhartia | MD & Director | 74.96M | 1976 |
| Arjun Shanker Bhartia | Joint MD & Director | 74.96M | 1987 |
| Ashish Mukkirwar | Chief Financial Officer & President | 0 | N/A |
| Arun Kumar Sharma | Chief Financial Officer & Group Treasurer | 0 | 1966 |
| A. Srivastava | Senior Vice President of Corporate Affairs | 0 | 1946 |
| Chandan Singh Sengar | President of Life Science Chemicals | 0 | 1964 |
| Pankaj Dhawan | VP & Head of Investor Relations | 0 | N/A |
| Prakash Chandra Bisht | Executive Vice President of Group Accounts | 0 | 1964 |
| Shantanu Jha | Group Chief Human Resources Officer | 0 | N/A |
| Sanjay Gupta | Executive Vice President & Head of Legal | 0 | 1966 |
Description
Jubilant Pharmova Limited functions as a comprehensive pharmaceutical enterprise with a global footprint, structured into three primary divisions: Pharmaceuticals; Contract Research & Development Services; and Proprietary Novel Drugs. The Pharmaceuticals segment is involved in a range of activities, including the production and distribution of allergy treatments, outsourced manufacturing of both sterile injectable and non-sterile medications, the creation of active pharmaceutical ingredients (APIs), and solid dose formulations. This division also markets radiopharmaceuticals through a network of 48 specialized pharmacies located across the United States. Its Contract Research & Development Services arm offers collaborative scientific investigation to pioneering pharmaceutical companies. Furthermore, the Proprietary Novel Drugs segment focuses on developing innovative therapies for conditions such as cancer and autoimmune diseases. Established in 1978 and headquartered in Noida, India, the company was formerly named Jubilant Life Sciences Limited before adopting its current designation, Jubilant Pharmova Limited, in February 2021.
